Variant #0000763537 (NC_000006.11:g.161139762A>G, NM_000301.3:c.988A>G (PLG))
| Individual ID |
00361882 |
| Chromosome |
6 |
| Allele |
Unknown |
| Affects function (as reported) |
Affects function |
| Affects function (by curator) |
Affects function |
| Classification method |
ACMG |
| Clinical classification |
pathogenic |
| DNA change (genomic) (Relative to hg19 / GRCh37) |
g.161139762A>G |
| DNA change (hg38) |
g.160718730A>G |
| Published as |
- |
| ISCN |
- |
| DB-ID |
PLG_000046 See all 4 reported entries |
| Variant remarks |
The heterozygous carriers of the family present with two bands of PLG type I and PLG type II approximately equal intensity and a susceptibility to zymogen activation. The Lys to Glu substitution introduces a Lys-binding site into the PLG kringle 3 domain, propably altering binding to kininogens. Plg residue 311 is Glu in most mammals. Glu311 in patients with HAE represents reversion to the ancestral condition. Substantial BK generation occurs during Plg-Glu311 cleavage of human HK, but not mouse HK. Mouse Plg, which has Glu311, did not liberate BK from human kininogens more rapidly than human PLG-Lys311. This indicates Glu311 is pathogenic in the context of human PLG when human kininogens are the substrates. |
| Reference |
Journal: Parsopoulou 2020 Journal: Dickeson 2022 |
| ClinVar ID |
ClinVar-RCV001507288.6 |
| dbSNP ID |
rs889957249 |
| Origin |
Germline |
| Segregation |
yes |
| Frequency |
0.00003 (gnomAD); 0.000004 (gnomAD_exome) |
| Re-site |
- |
| VIP |
- |
| Methylation |
- |
| Average frequency (gnomAD v.2.1.1) |
0 View details |
| Owner |
Christian Drouet |
| Database submission license |
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International |
| Created by |
Christian Drouet |
| Date created |
2021-04-11 18:49:19 +02:00 (CEST) |
| Date last edited |
2023-07-10 15:51:40 +02:00 (CEST) |

Variant on transcripts
Screenings
|
Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.
|